Houston Methodist — Sugar Land, Texas

Public research footprint of Houston Methodist, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Stopped or withdrawn

Most-studied conditions

Recurrent Ovarian Carcinoma · Endometrial Dedifferentiated Carcinoma · Recurrent Fallopian Tube Carcinoma · Recurrent Primary Peritoneal Carcinoma

Recently updated registry entries

NCT04267848 — Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy… (Recruiting)
NCT05256225 — Testing the Addition of Herceptin Hylecta or Phesgo to the Usual Chemotherapy for HER2… (Recruiting)
NCT05564377 — Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Houston Methodist?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 07, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.